This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - FrançiasSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page
HomeHomeVaccines HomepageLoadingDisease AreasDisease AreasRespiratory Syncytial Virus (RSV)Pneumococcal diseaseTick-borne encephalitis (TBE)Meningococcal diseaseDisease Areas

Menu

Close

Our BrandsOur BrandsABRYSVO®▼ (respiratory syncytial virus vaccine (bivalent, recombinant))Nimenrix® (meningococcal groups A, C, W-135 and Y conjugate vaccine)Trumenba®▼ (meningococcal group B vaccine (recombinant, adsorbed))Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed))TicoVac® (tick-borne encephalitis vaccine (whole virus inactivated))Vaccine TechnologiesVaccine TechnologiesMaternal ImmunisationConjugate TechnologyPolysaccharide VaccinesInactivated VaccinesSupport & ResourcesSupport & ResourcesClinic support materials

ABRYSVO®▼(Respiratory Syncytial Virus Vaccine [bivalent, recombinant]) Prescribing Information can be found here.

Maternal Immunisation: Protecting Newborns From BirthMaternal Immunisation is a promising public health strategy1.The Impact of Maternal Immunisation in the UK.This video features Dr Fatima Husain, an NHS Consultant Obstetrician and Gynaecologist, who explores why maternal immunisation is so important in the UK. Click here to find the full discussion guideLoading
How does Maternal Immunisation protect our babies? 

Antibodies generated by the mother are transferred to the foetus, and can offer protection from birth up to 6 months of age.2,3

Vaccines, such as inactivated influenza and Tdap, are routinely recommended in pregnant individuals in the majority of European countries including the UK.4

Discover more about Maternal Immunisation through our other Vodcast Videos.
 Engaging patients around Maternal Immunisation

In this video, Dr Fatima Husain and Dr George Kassianos discuss what difference is made when healthcare professionals invest much more time engaging with their patients around Maternal Immunisation.

 Supporting women to get information on Maternal Immunisation

In this video, Dr Fatima Husain and Dr George Kassianos discuss what experiences healthcare professionals have had in supporting women to get the right information on Maternal Immunisation.

HCPs, particularly maternal providers such as midwives, are pivotal in informing, educating, and promoting maternal immunisation.5,6-> 90% of pregnant women and women with children under 2 years of age identified midwives as their preferred source of information.7

 

-> Whether a vaccine is recommended by their GP is considered an important factor for pregnant women when contemplating vaccination during pregnancy.7

Make the most of your next conversation with your pregnant patients with our comprehensive discussion guide.

 Click for the full discussion guideLoading Register to receive personalised marketing information from Pfizer by email

Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.

 Sign up hereLoadingReferences:

1. Moniz MH, Beigi RH. Hum Vaccin Immunother. 2014;10(9): 2562–2570
2. Etti M et al. Am J Obstet Gynecol. 2022;226(4): 459–474. .
3. Niewiesk S. Front Immunol. 2014;5:446
4. Simionescu AA. et al. J Pers Med. 2021;11(11):1196.
5. Faucette, A.N. et al. Immunization of pregnant women: future of early infant protection. Human Vaccines and Immunotherapies. 2015;11(11): 2549-2555.
6. Collins, J. et al. Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated. Hum Vaccin Immunother. 2014. 10:2922- 2929.
7. Campbell, H. et al. Attitudes to immunisation in pregnancy among women in the UK targeted by such programmes. Br J Midwifery. 2015. 23:566-573 25.
​​References:
  1. Public Health England. The Green Book [published 2013; updated 2020]. Chapter 25: Pneumococcal. Available at https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25 Last accessed: May 2022
  2. UPDATE REFERENCES
PP-UNP-GBR-7231. December 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​
​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​